1. Priori SG, Blomström-Lundqvist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) - endorsed by: Associadeath from cardiovascular causes than from non- tion for European Paediatric and Congenital Cardiology (AEPC). cardiovascular causes.6,7 In keeping with this ob- Eur Heart J 2015;36:2793-867.
2. Kadish A, Dyer A, Daubert JP, et al. Prophylactic defibrillator servation, there was a suggestion of a differential implantation in patients with nonischemic dilated cardiomyoparesponse according to age in the present trial, thy. N Engl J Med 2004;350:2151-8. with a possible benefit of ICD therapy with regard 3. Desai AS, Fang JC, Maisel WH, Baughman KL. Implantable defibrillators for the prevention of mortality in patients with to death from any cause among younger patients nonischemic cardiomyopathy: a meta-analysis of randomized (<68 years of age). The background rate of death controlled trials. JAMA 2004;292:2874-9. from cardiovascular causes and sudden cardiac 4. Køber L, Thune JJ, Nielsen JC, et al. Defibrillator implantation in patients with nonischemic systolic heart failure. N Engl death could also be reduced even more in prac- J Med 2016;375:1221-30. tice by further optimizing pharmacologic therapy, 5. Rush CJ, Campbell RT, Jhund PS, et al. Falling cardiovascu-